The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Urinary incontinence, or leakage of urine, is a very common condition for women of all ages, ethnicities and backgrounds.

A football fan who has stage four prostate cancer is backing a campaign for sanitary bins to be put in men's toilets at ...

WHEN was the last time you thought about your pelvic floor? Maybe never? If so, it’s time to start paying some attention as ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Driven by a combination of demographic, social, and technological factors, the disposable incontinence products industry is ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

Medical experts share their answers to all your questions on bladder problems, from urinary tract infections to odd urine ...

Many people believe that urinary tract infections (UTIs) and incontinence are more common in women, but they can also affect ...

Background: Urinary incontinence (UI), particularly urge urinary incontinence ... The odds ratio (OR) and 95% confidence interval (95% CI) of the relationship between CDAI and male UUI were ...

One older study cites lower body index as a risk factor for postoperative urinary incontinence. However ... while newer sources state that the condition is more common in men. Some underlying ...

Roughly one in every three men over the age of 65 in the UK face urinary incontinence, according to the Prostate Cancer UK charity An athlete and a former semi-pro footballer says he has been "put ...